Escolar Documentos
Profissional Documentos
Cultura Documentos
& Gynae
G.R. MEDICAL COLLEGE, GWALIOR
SEMINAR PRESENTATION
MANAGEMENT OF
PRETERM LABOUR
Chairperson Guide
Prof. Dr. (Mrs.) V. Agrawal Prof . & Dr J Bindal
Prof. & HOD of Obst. & Gynae Department of Obst. & Gynae
G.R. Medical College Gwalior G.R. Medical College Gwalior
Presented by
Dr. Divya Kakrani
IIIrd Year R.S.O. Obst. & Gynae
MANAGEMENT OF PRETERM
LABOUR
DEFINITION
PREERM BIRTH-
CAUSES &
OUTCOME
PREDICTION
ANTECEDENT
FACTORS
PREVENTION
TREATMENT
DEFINITION
membranes(PROM)
Twins and high order births
Drugs like cocaine or methamphetamine
Uterine and cervical causes-fibroid uterus,
estriol level
Administration of betamethasone to effect
2001)
Screening for fetal fibronectin (fFN)
Basement membrane protein produced by the
hepatocytes , fibroblasts , endothelial cells , fetal
amnion and functions as an ‘adhesion binder’.
attachment of the placenta and membranes to the
uterine decidua
Present in maternal blood and amniotic fluid
Normally detectable in cervical secretions until 16-
20 weeks of gestation.
After 24 weeks (>50 ng/ml ) of gestation may
predisposed to PTL.
Funneling of cervix if present increases risk
ANTECEDANTS AND CONTRIBUTING
FACTORS
THREATENED ABORTIONS
LIFESTYLE FACTORS-smoking , inadequate maternal
wt gain , illicit drug usage
WORK DURING PREGNANCY- only long and hard
physical labour are associated
GENETIC FACTORS
PERIODONTAL DISEASE-chronic anaerobic inflammation of
gums,
BIRTH DEFECTS
INTERVAL BETWEEN PREGNANCIES- smaller intervals more
associated
PRIOR PRETERM BIRTHS
PREVENTION OF PRETERM BIRTH
PROGESTERONE
Weekly im injections reduce PTL.
Daily 100mg progesterone suppositories
under way.
17 Hydroxy -Progesterone Caproate
decreases PTL
Smoking cessation
Self monitoring of vaginal pH and yoghurt
treatment
Cervical circlage
For cervical insufficiency which complicates
0.1-2% of all pregnancies and is responsible
for 20% of late 2nd trimester losses
&sedation
Tocolytics
Hydration
Intravenous hydration does not
seem to be beneficial, even during
the period of evaluation soon after
admission,
Women with evidence of
polyhydramnios :
( to have renal effects
of indomethacin)
Indomethacin
Capsule 25mg oral
Amp 50mg
Rectal Supp 100 mg
50 mg Loading dose
Then 25-50mg /6hs
Indomethacin
Fetal risk:
Premature closure of the ductus.
Renal and cerebral
vasoconstriction.
Necrotising enterocolitis
General contraindications
Acute fetal distress (except intrauterine
resuscitation)
Chorioamnionitis
Eclampsia or severe preeclampsia
Fetal demise (singleton)
Fetal maturity
Maternal hemodynamic instability
Contraindications for specific tocolytic
agents
Beta-mimetic agents
Maternal cardiac rhythm disturbance or other cardiac
disease
Poorly controlled diabetes, thyrotoxicosis or
hypertension
Magnesium sulfate
Hypocalcemia
Myasthenia gravis
Renal failure
Indomethacin (Indocin)
Asthma
Coronary artery disease
Gastrointestinal bleeding (active or past history)
Oligohydramnios
Renal failure
Suspected fetal cardiac or renal anomaly
Beta-adrenergic agents
Hyperglycemia
Hypokalemia
Hypotension
Pulmonary edema
Cardiac insufficiency
Arrhythmias
Myocardial ischemia
Maternal death
Magnesium sulfate
Pulmonary edema
Respiratory depression
Cardiac arrest
Maternal tetany
Profound muscular paralysis
Profound hypotension
Indomethacin (Indocin)
Hepatitis
Renal failure
Gastrointestinal bleeding
Nifedipine (Adalat, Procardia)
Transient hypotension
B -Sympathomimetic Agents.
Maternal: pulmonary edema,
myocardial ischemia, arrhythmia, and
even maternal death.
Fetal : arrhythmia, cardiac septal
CARBON MONOOXIDE
HUMAN GONADOTROPIN
Thank You